Your browser doesn't support javascript.
loading
Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study.
Hamilton, C A; Miller, A; Casablanca, Y; Horowitz, N S; Rungruang, B; Krivak, T C; Richard, S D; Rodriguez, N; Birrer, M J; Backes, F J; Geller, M A; Quinn, M; Goodheart, M J; Mutch, D G; Kavanagh, J J; Maxwell, G L; Bookman, M A.
Affiliation
  • Hamilton CA; Gynecologic Cancer Center of Excellence, John P. Murtha Cancer Center, Walter Reed National Military Medical Center and Uniformed Services University of the Health Sciences, Bethesda, MD, United States. Electronic address: chad.a.hamilton2.mil@mail.mil.
  • Miller A; NRG Oncology Statistics and Data Management Center/Gynecologic Oncology Group, Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY, United States.
  • Casablanca Y; Gynecologic Cancer Center of Excellence, John P. Murtha Cancer Center, Walter Reed National Military Medical Center and Uniformed Services University of the Health Sciences, Bethesda, MD, United States.
  • Horowitz NS; Division of Gynecologic Oncology, Brigham & Women's Hospital, Boston, MA, United States.
  • Rungruang B; Division of Gynecologic Oncology, Medical College of Georgia at Augusta University, Augusta, GA, United States.
  • Krivak TC; Division of Gynecologic Oncology, Western Pennsylvania Hospital, Pittsburgh, PA, United States.
  • Richard SD; Division of Gynecologic Oncology, Hahnemann University Hospital/Drexel University College of Medicine, Philadelphia, PA, United States.
  • Rodriguez N; Division of Gynecologic Oncology, Loma Linda University Medical Center, Loma Linda, CA, United States.
  • Birrer MJ; Gillette Center for Gynecologic Oncology, Massachusetts General Hospital, Boston, MA, United States.
  • Backes FJ; Division of Gynecologic Oncology, Ohio State University Wexner Medical Center and James Cancer Hospital, Columbus, OH, United States.
  • Geller MA; Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, United States.
  • Quinn M; Gynaecological Oncology, ANZGOG, Royal Women's Hospital and University of Melbourne, Australia.
  • Goodheart MJ; Gynecologic Oncology, University of Iowa, Iowa City, IA, United States.
  • Mutch DG; Gynecologic Oncology, Washington University, St. Louis, MO, United States.
  • Kavanagh JJ; MD Anderson Cancer Center, Houston, TX, United States.
  • Maxwell GL; Inova Fairfax Hospital Department of Obstetrics and Gynecology, Inova Schar Cancer Institute, Falls Church, VA, United States.
  • Bookman MA; US Oncology Research and Arizona Oncology, Tucson, AZ, United States.
Gynecol Oncol ; 148(2): 275-280, 2018 02.
Article in En | MEDLINE | ID: mdl-29195926

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Peritoneal Neoplasms / Neoplasms, Glandular and Epithelial Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: Gynecol Oncol Year: 2018 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Peritoneal Neoplasms / Neoplasms, Glandular and Epithelial Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Country/Region as subject: America do norte Language: En Journal: Gynecol Oncol Year: 2018 Document type: Article Country of publication: